Literature DB >> 27979757

Congenital retinal macrovessel associated with vitreous hemorrhage.

Neha Goel1, Vinod Kumar2, Basudeb Ghosh3.   

Abstract

A "congenital retinal macrovessel" (CRM) is an aberrant retinal vessel (frequently a vein) that traverses the central macula and supplies or drains both above and below the horizontal raphe. It is an uncommon entity that is usually disclosed on routine examination and may rarely cause a compromised visual acuity. We describe the case of an adolescent girl who underwent vitrectomy for vitreous hemorrhage and was found to have a CRM with vascular abnormalities. To our knowledge, this is the first report of vitreous hemorrhage secondary to a CRM.
Copyright © 2017 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27979757     DOI: 10.1016/j.jaapos.2016.09.018

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  5 in total

1.  Congenital retinal macrovessel with intracranial venous malformation in a pediatric patient: a case report.

Authors:  Hyeon Jin Park; Sook Hyun Yoon; Sook Young Kim; Donghun Lee
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

2.  Multimodal imaging of aberrant macular microvessel crossing the foveal avascular zone in two young adults.

Authors:  Xianming Jiang; Cong Zheng; Fangfang Du; Shibei Ai
Journal:  BMC Ophthalmol       Date:  2020-05-25       Impact factor: 2.209

3.  A case of congenital retinal macrovessel in an otherwise normal eye.

Authors:  Margaret R Strampe; William J Wirostko; Joseph Carroll
Journal:  Am J Ophthalmol Case Rep       Date:  2017-09-09

4.  Multimodal Imaging Analysis in a Case with Congenital Fovea-Involving Retinal Macrovessel and Excellent Visual Acuity.

Authors:  Vishal Shah; M Ashwin Reddy; Vasilios P Papastefanou
Journal:  Case Rep Ophthalmol Med       Date:  2017-10-19

5.  Congenital retinal macrovessel in a patient with rhegmatogenous retinal detachment.

Authors:  Vinod Kumar; Neha Goel
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.